On Monday, Shares of General Electric Company (NYSE:GE), lost -1.61% to $26.92.
General Electric Company, declared its ‘Industrial Dojo,’ in partnership with the Cloud Foundry Foundation, to strengthen its efforts to solve the world’s biggest industrial challenges. The Cloud Foundry Dojo program allows software developers to immerse themselves in open source projects to quickly learn the inner workings of the core technology and the unique agile development environment, in addition to recommended methodologies for contributing code. GE also declared it will work with the Cloud Foundry community to develop and contribute open source code to the Cloud Foundry Foundation that will route all industrial messaging protocols.
General Electric Company (GE) operates as an infrastructure and financial services company worldwide. The company’s Power and Water segment offers gas, steam and aeroderivative turbines, nuclear reactors, generators, combined cycle systems, controls, and related services; wind turbines; and water treatment services and equipment.
Shares of EMC Corporation (NYSE:EMC), declined -0.41% to $26.82, during its last trading session.
EMC Corporation, declared that the 2015 EMC Heritage Trust Project is now accepting nominations for grants. Grants will support projects that practice and encourage the stewardship of cultural information in local communities around the world.
To date, EMC has recognized more than 45 projects with Heritage Trust grants and, through the broader EMC Information Preservation Initiative, has donated more than $37 million to assist advance the conservation of information heritage globally. Founded in 2007, the EMC Information Heritage Initiative program recognizes organizations and individuals that protect and preserve cultural information from around the world through digitization, allowing readily accessible online research and education. In conjunction with the program, the EMC Heritage Trust Project recognizes and supports local people and projects that practice and inspire the digital stewardship of the world’s information heritage.
This year, EMC’s Heritage Trust Project will accept applications in 24 countries: Argentina, Australia, Brazil, Canada (not taking into account Quebec), Chile, Columbia, France, Germany, Ghana, India, Ireland, Japan, Kenya, Mexico, New Zealand, Philippines, Saudi Arabia, South Africa, South Korea, Tanzania, Thailand, Turkey, United Kingdom, and United States. Applications will be accepted from May 6 – June 19. Winners will be declared in September 2015.
EMC Corporation develops, delivers, and supports information infrastructure and virtual infrastructure technologies, solutions, and services. It offers enterprise storage systems and software deployed in storage area networks (SAN), networked attached storage (NAS), unified storage combining NAS and SAN, object storage, and/or direct attached storage environments, in addition to provides a portfolio of backup products that support a range of enterprise application workloads.
At the end of Monday’s trade, Shares of Noble Corporation plc (NYSE:NE), gained 0.23% to $17.14.
On April 29, Noble Corporation, stated first quarter 2015 net income from ongoing operations attributable to Noble Corporation of $178 million, or $0.72 per diluted share. The results contrast to a loss from ongoing operations in the fourth quarter of 2014 of $595 million, or $2.38 per diluted share. Fourth quarter 2014 results comprised of an after-tax charge of $713 million, or $2.86 per diluted share, related to the impairment of three rigs and the Company’s total goodwill balance. Not taking into account the fourth quarter impairment charge, net income from ongoing operations would have been $119 million, or $0.47 per diluted share. For the first quarter of 2014, net income from ongoing operations was $155 million, or $0.60 per diluted share. Revenues for the first quarter of 2015 totaled $804 million contrast to $805 million in the fourth quarter of 2014 and $795 million in the first quarter of 2014.
David W. Williams, Chairman, President and Chief Executive Officer of Noble Corporation plc, pointed to the Company’s operations performance as a key driver of the strong financial results in the quarter. “Improved revenue efficiency resulting from fleet downtime of less than 4 percent represented outstanding performance and was well below our guidance for the quarter. This accomplishment is particularly noteworthy given the dramatic shift of our fleet over the past two years toward a higher mix of premium floating and jackup rigs. The strong execution was, in part, responsible for an 18 percent decline in contract drilling operating expenses when contrast to the fourth quarter of 2014, as rig repair costs were minimized. We also benefited during the quarter from further cost control initiatives as we adjusted our operations to the current pace of offshore activity. The excellent operating performance led to higher profitability and a lower-than-predictable effective tax rate, which contributed to the strong financial results.
“We entered 2015 well aware of the formidable industry challenges resulting from the combination of lower crude oil prices, reduced upstream spending by customers and excess offshore rig capacity. In the face of weaker industry fundamentals, we remain focused on efforts to capture additional cost reductions and improve operating efficiencies to maintain healthy contract drilling services margins while upholding our high operational standards.”
Noble Corporation plc operates as an offshore drilling contractor for the oil and gas industry worldwide. It owns and operates a fleet of mobile offshore drilling units. As of December 31, 2014, the company operated a fleet of 15 jackups, 9 drillships, and 8 semisubmersibles, counting 1 high-specification, harsh environment jackup under construction.
Finally, AbbVie Inc. (NYSE:ABBV), ended its last trade with -0.06% loss, and closed at $65.20.
AbbVie, declared 17 abstracts from studies of the company’s oncology pipeline are being presented at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO), May 29 - June 2, in Chicago. Notably, data will be presented from investigational studies of venetoclax, a B-cell lymphoma-2 (BCL-2) selective inhibitor, in relapsed or refractory multiple myeloma (R/R MM) patients, and veliparib (ABT-888), a poly (adenosine diphosphate [ADP]–ribose) polymerase (PARP) inhibitor, in advanced non-small cell lung cancer (NSCLC) patients with a history of smoking – a factor identified as the number one risk for lung cancer in the United States.
“These data demonstrate our continued commitment to the patients who are affected by a wide variety of cancers,” said Michael Severino, M.D., executive vice president of research and development and chief scientific officer, AbbVie. “AbbVie has a history of developing therapies for patients in need, and our pursuit of new study results for these compounds reinforces our intent to make a noteworthy impact in oncology.”
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products comprise HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-oral, short-course, interferon-free therapy, with or without ribavirin, for adult patients with genotype 1 chronic hepatitis, counting those with compensated cirrhosis; Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in people with HIV-1; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1 infection; and Synagis to prevent respiratory syncytial virus infection in high risk infants.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
